These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 9371349)
1. Ribosylative inactivation of rifampin by Mycobacterium smegmatis is a principal contributor to its low susceptibility to this antibiotic. Quan S; Venter H; Dabbs ER Antimicrob Agents Chemother; 1997 Nov; 41(11):2456-60. PubMed ID: 9371349 [TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of a new intermediate in the ribosylative inactivation pathway of rifampin by Mycobacterium smegmatis. Imai T; Watanabe K; Mikami Y; Yazawa K; Ando A; Nagata Y; Morisaki N; Hashimoto Y; Furihata K; Dabbs ER Microb Drug Resist; 1999; 5(4):259-64. PubMed ID: 10647083 [TBL] [Abstract][Full Text] [Related]
3. Light inhibits rifampicin inactivation and reduces rifampicin resistance due to a cloned mycobacterial ADP-ribosylation gene. Dabbs ER; Quan S FEMS Microbiol Lett; 2000 Jan; 182(1):105-9. PubMed ID: 10612740 [TBL] [Abstract][Full Text] [Related]
4. Sequence and analysis of the rpoB gene of Mycobacterium smegmatis. Hetherington SV; Watson AS; Patrick CC Antimicrob Agents Chemother; 1995 Sep; 39(9):2164-6. PubMed ID: 8540740 [TBL] [Abstract][Full Text] [Related]
11. [Investigation of drug-resistance to rifampin and rpoB gene sequence analysis of Mycobacterium abscessus]. Sha W; Weng XH; Xiao HP; He GJ Zhonghua Jie He He Hu Xi Za Zhi; 2003 Sep; 26(9):544-7. PubMed ID: 14521758 [TBL] [Abstract][Full Text] [Related]
12. Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants. Huitric E; Werngren J; Juréen P; Hoffner S Antimicrob Agents Chemother; 2006 Aug; 50(8):2860-2. PubMed ID: 16870787 [TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of kanamycin and viomycin resistance in Mycobacterium smegmatis by use of the conjugation system. Taniguchi H; Chang B; Abe C; Nikaido Y; Mizuguchi Y; Yoshida SI J Bacteriol; 1997 Aug; 179(15):4795-801. PubMed ID: 9244267 [TBL] [Abstract][Full Text] [Related]
14. Rifampin resistance in Mycobacterium kansasii is associated with rpoB mutations. Klein JL; Brown TJ; French GL Antimicrob Agents Chemother; 2001 Nov; 45(11):3056-8. PubMed ID: 11600355 [TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of codon 548 in the rpoB gene involved in Mycobacterium tuberculosis resistance to rifampin. Horng YT; Jeng WY; Chen YY; Liu CH; Dou HY; Lee JJ; Chang KC; Chien CC; Soo PC Antimicrob Agents Chemother; 2015 Mar; 59(3):1542-8. PubMed ID: 25534743 [TBL] [Abstract][Full Text] [Related]
16. Rifamycin antibiotic resistance by ADP-ribosylation: Structure and diversity of Arr. Baysarowich J; Koteva K; Hughes DW; Ejim L; Griffiths E; Zhang K; Junop M; Wright GD Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4886-91. PubMed ID: 18349144 [TBL] [Abstract][Full Text] [Related]
17. Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis. Piatek AS; Tyagi S; Pol AC; Telenti A; Miller LP; Kramer FR; Alland D Nat Biotechnol; 1998 Apr; 16(4):359-63. PubMed ID: 9555727 [TBL] [Abstract][Full Text] [Related]
18. Structure determination of ribosylated rifampicin and its derivative: new inactivated metabolites of rifampicin by mycobacterial strains. Morisaki N; Kobayashi H; Iwasaki S; Furihata K; Dabbs ER; Yazawa K; Mikami Y J Antibiot (Tokyo); 1995 Nov; 48(11):1299-303. PubMed ID: 8557572 [TBL] [Abstract][Full Text] [Related]